MAUDE Adverse Event Report: ANGIODYNAMICS BIOFLO PORT; PORT & CATHETER, IMPLANTED

Model Number 44014

Device Problem Migration (4003)

Patient Problem Infiltration into Tissue (1931)

Event Date 04/17/2020

Event Type  Injury  

Manufacturer Narrative

The reported defective device has been returned to the manufacturer and an investigation into the root cause for event is currently in progress.The results of the device evaluation will be sent via a follow up medwatch.Complaint # (b)(4).

Event Description

An angiodynamics vascular consultant reported that part of a 8f bioflo plastic port's stem eroded through the skin of a patient.The patient was receiving intermittent chemotherapy that would infuse over the course of 2-3 days continuously.Patient described the port area as moist along the entire base when receiving infusions.It is believed the port may have a small leak.It was reported the patient exhibited no signs of overt infection.A small area of clean skin breakdown at the lateral corner of the incision was nost likely due to pressure/skin thinning.Port was removed and replaced in the opposite side of the chest.The patient was reported as stable.The reported defective disposable device has been returned to the manufacturer for evaluation.

Manufacturer Narrative

Returned for evaluation was a bioflo port.As received, approximately 25cm of the catheter and connector were attached to the bioflo port.The port septum contained bio material {blood} inside.No visual defects were noted to the returned bioflo port.Functional testing was performed.The leak test of assembled device as received noted no leaks.The customer's complaint description of a leak in the port could not be confirmed.The port was pressurized with air at 50 psi and submerged in water.No leaks were detected.No manufacturing non-conformances were observed during sample review.A root cause for the reported leak cannot be determined.Based on the evaluation of the returned device (no leaks) the break down of the patient's skin around the body does not appear to be related to the port device or leakage of the fluids from the port device.The root cause for the skin erosion cannot be determined.A review of the device history records was performed for the reported packaging and component lots for any deviations related to the reported defect of the complaint.The review confirms that the lots met all material, assembly, and performance specifications.Labeling review: labeling review: the dfu for this product contains the following precautions: precautions: carefully read and follow all instructions prior to use.Only licensed health care practitioners should insert, manipulate, and remove these devices.Intended use/ indications for use: the bioflo port with endexo technology, bioflo dual port with endexo technology and the bioflo port with endexo and pasv valve technology are indicated for patients who require long-term access to the central venous system for administration of fluids including but not limited to hydration fluids, chemotherapy, analgesics, nutritional therapy and blood products.The device is also indicated for blood specimen withdrawal.Maintenance: to help prevent clot formation and catheter blockage, the bioflo port should be filled with sterile heparinized saline after each use.Bioflo ports with the pasv valve may be flushed and locked with either normal saline or heparinized saline per institutional protocol.If the port remains unused for long periods of time, the lock should be changed at least once every four weeks.Precaution: some patients may be hypersensitive to heparin or suffer from heparin induced thrombocytopenia (hit) and these patients must not have their port primed with heparinized saline.A review of the angiodynamics complaint system noted no trends for this complaint type and product family.This type of complaint will continue to be monitored for trends.Complaint # (b)(4).

• Brand Name: BIOFLO PORT
• Type of Device: PORT & CATHETER, IMPLANTED
• Manufacturer (Section D): ANGIODYNAMICS; 10 glens falls technical park; glens falls, ny
• MDR Report Key: 10048579
• MDR Text Key: 190996661
• Report Number: 1317056-2020-00089
• Device Sequence Number: 1
• Product Code: LJT
• UDI-Device Identifier: H965440140
• UDI-Public: H965440140
• Combination Product (y/n): N
• PMA/PMN Number: K131694
• Number of Events Reported: 1
• Summary Report (Y/N): N
• Report Source: Manufacturer
• Source Type: company representative,health
• Type of Report: Initial,Followup
• Report Date: 06/02/2020

1 Device was Involved in the Event

1 Patient was Involved in the Event

• Date FDA Received: 05/12/2020
• Is this an Adverse Event Report?: Yes
• Is this a Product Problem Report?: No
• Device Operator: Health Professional
• Device Expiration Date: 11/30/2021
• Device Model Number: 44014
• Device Catalogue Number: 44014
• Was Device Available for Evaluation?: Device Returned to Manufacturer
• Date Returned to Manufacturer: 04/24/2020
• Date Manufacturer Received: 04/17/2020
• Is This a Reprocessed and Reused Single-Use Device?: No
• Patient Sequence Number: 1
• Patient Outcome(s): Required Intervention
• Patient Age: 71 YR